3Felmingham D, Robbings MJ, Ghosh G, et al. An in vitro characterization of cefditoren, a new oral cephalosporin. Drugs Exptl Clin Res. 1994,20(4): 123.
4Tamura A, Okamoto R, Yoshida T, et al. In vitro and in vivo antibacterial activities of ME 1207, a new oral cephalosporin. Antimicrob Agents Chemother, 1988, 32 (9): 1421.
5Felmingham D, Robbings MJ,Ghosh G, et al. An in vitro characterization of cefditoren, a new oral cephalosporin. Drugs Exptl Clin Res. 1994,20(4): 123.
7Shimada K, Matsumoto T, Komiya I, et al. Phase I clinical studies on a novel oral cephem antibiotic, ME1207. Chemother, 1992 ,40(Suppl 2):105-119.
8Nishino T, Takata T, Otsuki M, et al. In vitro and in vivo antibacterial activity of ME1207, a new oral cephem antibiotic. Chemother, 1992, 40(Suppl 2): 37-50.
9Pressed review with community acquired infection. Jpn J Antibiot,(Suppl B) 2001, 52.
10Li JT, Hou F, Lu H, et al. Phase I clinical trial of Cefditoren pivoxil (ME-1207): Pharmacokinetics in healthy volunteers. Drugs Exptl Clin Res, 1997, ⅩⅩⅩⅢ(5/6): 145-150.
9Lode H,Fassbender M,Schaberg T,et al.Comparative pharmaco kinetics of the new oral cephalosporins[J].Drugs,1994,47(Suppl.3):10-20.
10Viseman LR,Baflour JA.Ceftibuten,a review of its antibacterial activity,pharmacokinetic properties and clinical efficacy[J].Drugs,1994,47(5):784-808.
